Header image

Concurrent 4B: Abstract Session

Tracks
Track 2
Thursday, October 16, 2025
2:00 PM - 3:30 PM

Speaker

Dr. Catherine Chappell
Associate Professor
University Of Pittsburgh

Safety, Tolerability, and Outcomes of Sofosbuvir/Velpatasvir in Treatment of Chronic Hepatitis C Virus during Pregnancy: interim results from the STORC study

2:00 PM - 2:15 PM

Abstract (.pdf)

Biography

Miss Grace Burton-Mckeich
Phd Student
Unsw / The Kirby Institute

HEALTHCARE PROVIDER PERSPECTIVES ON MANAGING HEPATITIS C TREATMENT DURING PREGNANCY: CURRENT PRACTICES AND PATHWAYS FORWARD

2:15 PM - 2:30 PM

Abstract (.pdf)

Biography

Grace Burton-McKeich is a research assistant at the Kirby Institute, UNSW, Sydney. She has an honours degree in Health Sciences from the University of Auckland. In her career she is driven to reduce negative outcomes caused by infectious diseases among vulnerable populations.
Dr. Madeline Mccrary
Assistant Professor Of Medicine
Washington University School of Medicine

Hepatitis C treatment in pregnancy: implementation of a shared decision-making care model

2:30 PM - 2:45 PM

Abstract (.pdf)

Biography

Dr. Madeline McCrary is an infectious diseases and addiction medicine physician and Assistant Professor at the Washington University School of Medicine in St. Louis, MO USA. She is interested in the clinical care of patients who use drugs and innovative models improving access to Hepatitis C treatment including in pregnancy.
Dr Joseph Gregory Rosen
Assistant Professor (Research)
Brown University Warren Alpert Medical School

ADAPTING AND TAILORING OPIOID AGONIST TREATMENT SERVICES FOR FEMALE SEX WORKERS LIVING WITH HIV IN SOUTH AFRICA: AN IMPLEMENTATION PLANNING STUDY

2:45 PM - 3:00 PM

Abstract (.pdf)

Biography

Dr. Joseph "Greg" Rosen is an Assistant Professor of Medicine and Epidemiology (Research) at Brown University and a Research Scientist at Rhode Island Hospital. His research harnesses workforce capacity-enhancement strategies and health system reconfigurations to optimize delivery of HIV and substance use services to marginalized populations globally.
Ms Tamara Barnett
Hepatitis C Nurse Coordinator
Cool Aid Community Health Centre

A GLOBAL PRESPECTIVE ON WOMEN AND HIV PREVENTION MEDICATION: A SCOPING REVIEW OF WOMEN’S PRESPECTIVES AND ENGAGEMENT ACROSS THE CONTINUM

3:00 PM - 3:05 PM

Abstract (.pdf)

Biography

Tamara Barnett is a certified practice registered nurse at Cool Aid Community Health Centre in Victoria, BC. She coordinates the internationally award winning and recognized, nurse-led hepatitis C treatment program, which includes innovative prison- and peer-led models of care. She is also a MScN student at York University.
Dr Ashleigh Stewart
Researcher
Burnet Insitute

THE EFFECT OF SEX ON THE INCIDENCE OF AMBULANCE ATTENDANCES AMONG PEOPLE WHO INJECT DRUGS IN VICTORIA, AUSTRALIA

3:05 PM - 3:10 PM

Abstract (.pdf)

Biography

Ash is a post-doctoral researcher at the Burnet in Melbourne, Australia. She works primarily in infectious diseases and research related to the health outcomes and drug-related harms experienced by people who inject drugs. Her pronouns are she/her.
Ms. Hannah Manley
Study Coordinator
Albert Einstein College Of Medicine

GENDER DIFFERENCES IN TRANSACTIONAL SEX AMONG WOMEN AND MEN WHO INJECT DRUGS IN KENYA

3:10 PM - 3:15 PM

Abstract (.pdf)

Biography

Hannah Manley, MA is a Study Coordinator at Albert Einstein College of Medicine in New York. She coordinates work aimed at informing a targeted public health strategy to prevent HIV and other blood borne infection transmission among PWID in Kenya. Previously she has worked on suicide risk and prevention research.
Agenda Item Image
Mr Joshua Dawe
PhD Researcher
University of Bristol

THE RISKS OF HCV AND HIV INCIDENCE AMONG PEOPLE WHO INJECT DRUGS WHO ALSO UNDERTAKE SEX WORK OR MALE-WITH-MALE SEXUAL ACTIVITY: A META-ANALYSIS COMBINING PUBLISHED AND UNPUBLISHED ESTIMATES

3:15 PM - 3:20 PM

Abstract (.pdf)

Biography

I am a third year PhD candidate at the University of Bristol, with interests in epidemiology and infectious disease modelling. I am a passionate advocate for the rights and health of people who experience disproportionately higher risk of blood-borne virus acquisition.
Miss Jade Lane
Research And Technical Advisor
Burnet Institute

WE KEEP US SAFE: EARLY FINDINGS FROM A SURVIVOR-LED STUDY ON COMMUNITY-LED RESPONSES TO DOMESTIC, FAMILY, AND SEXUAL VIOLENCE (DFSV) AMONG CRIMINALISED PEOPLE WHO USE DRUGS

3:20 PM - 3:25 PM

Abstract (.pdf)

Biography

Jade is an antiviolence activist, organiser, and research practitioner working alongside communities impacted by state violence. Jade’s work spans public health, emergency management, and gender-based violence prevention and emphasises community-led interventions that promote harm reduction and decarceration. Jade’s practice is underpinned by lived experience of criminalisation and drug use.
loading